CVR: 27394019
Secondary names: WELLCOME DANMARK A/S, WELLCOME BIOTECHNOLOGY A/S, WELLCOME DIAGNOSTICS A/S
Previous names: GLAXO LÆGEMIDLER A/S, GLAXO WELLCOME A/S, GLAXO DANMARK A/S
GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The company is owned by Setfirst Limited. The company has 80 employees. In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity amounted to DKK 39,017,000.
The financial health of GLAXOSMITHKLINE PHARMA A/S appears stable, with a consistent upward trend in both revenue and profit over the past five years. Revenue increased from 440.3 million DKK in 2022 to 580.8 million DKK in 2025, while profit rose from 11.1 million DKK to 13.1 million DKK in the same period, indicating a growing demand for their pharmaceutical products. The company's equity has also improved, reaching 39 million DKK in 2025, which reflects a solid foundation for future growth. However, the profit margins remain relatively modest, suggesting potential concerns regarding operational efficiency. Overall, the company maintains a favorable position within the pharmaceutical wholesale industry, benefiting from steady growth and increasing market presence.
AI-generated summary
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive handel
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 580.8 mio. | 13.1 mio. | 120.7 mio. | 39 mio. | 71000 | |
| 2024 | 548.5 mio. | 12.2 mio. | 99.1 mio. | 38.1 mio. | 73 | |
| 2023 | 474.5 mio. | 12 mio. | 117.3 mio. | 37.9 mio. | 72 | |
| 2022 | 440.3 mio. | 11.1 mio. | 115.8 mio. | 36.9 mio. | 68 | |
| 2021 | 445.9 mio. | 9 mio. | 137.5 mio. | 34.8 mio. | 66 | |
| 2020 | 441.7 mio. | 12.3 mio. | 160.1 mio. | 37.8 mio. | 62 | |
| 2019 | 417.4 mio. | 11.1 mio. | 173.6 mio. | 35.5 mio. | 68 | |
| 2018 | 413.8 mio. | 17.5 mio. | 231.7 mio. | 39.4 mio. | 80 | |
| 2017 | 426.9 mio. | 9.6 mio. | 192 mio. | 35.4 mio. | 87 | |
| 2016 | 366.5 mio. | 1.9 mio. | 332 mio. | 25.8 mio. | 92 | |
| 2015 | 338.9 mio. | 3.7 mio. | 235.8 mio. | 147.9 mio. | 87 | |
| 2014 | 371.5 mio. | 11.8 mio. | 229.9 mio. | 144.3 mio. | 92 | |
| 2013 | 364.3 mio. | 14.5 mio. | 267 mio. | 146.9 mio. | 109 |
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
2 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 36359100, new email: [email protected], new website: https://www.gsk.com (July 16, 2026).
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2025. Revenue came to DKK 580,769,000, and the net result was DKK 13,123,000.
As of June 18, 2026, Alastair William Jones has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of June 18, 2026, Joshua Rhys Williams has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has won the tender "Rammekontrakt om levering af Hepatitis A vaccine 2026 - 2030" issued by Statens Serum Institut worth 1 DKK.
GLAXOSMITHKLINE PHARMA A/S has won the tender "Udbudsnummer 1" issued by Amgros I/S worth 19,000,000 DKK.
Contact info changed: new phone: 36359100, new email: [email protected], new website: https://www.gsk.com (April 17, 2026).
As of August 26, 2025, Diederik Maarten Eijsvogel has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of August 26, 2025, Dominika M Wiktor-Brown has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of August 26, 2025, Diederik Maarten Eijsvogel is registered as director of GLAXOSMITHKLINE PHARMA A/S.
As of August 26, 2025, Dominika M Wiktor-Brown has stepped down as director of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2024. Revenue came to DKK 548,470,000, and the net result was DKK 12,240,000.
As of June 18, 2025, Luciano Alves de Andrade has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of June 18, 2025, Patrick Gerard Connor has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 15, 2025, Joshua Rhys Williams has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 15, 2025, Hemal Depan Malde has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2023. Revenue came to DKK 474,477,000, and the net result was DKK 12,003,000.
As of November 1, 2023, Tetiana Luczkiw has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2022. Revenue came to DKK 440,283,000, and the net result was DKK 11,068,000.
As of May 1, 2023, Hemal Depan Malde has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2023, Helle Ann Hellberg has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2023, Dominika M Wiktor-Brown has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2023, David Mattheus Fredericus Rademakers has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2023, Dominika M Wiktor-Brown is registered as director of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2023, David Mattheus Fredericus Rademakers has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2021. Revenue came to DKK 445,873,000, and the net result was DKK 8,984,000.
As of January 1, 2022, Patrick Gerard Connor has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 1, 2022, Anne Margaret Belcher has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2020. Revenue came to DKK 441,702,000, and the net result was DKK 12,271,000.
As of September 30, 2020, Tetiana Luczkiw has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of September 30, 2020, Ole Jensen-Dahm has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of July 1, 2020, Anne Margaret Belcher has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of July 1, 2020, Neale Andrew Belson has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2019. Revenue came to DKK 417,448,000, and the net result was DKK 11,096,000.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2018. Revenue came to DKK 413,846,000, and the net result was DKK 17,523,000.
As of October 30, 2018, David Mattheus Fredericus Rademakers has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of October 30, 2018, Saskia Fontein has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of October 30, 2018, David Mattheus Fredericus Rademakers is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of October 30, 2018, Saskia Fontein has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2017. Revenue came to DKK 426,868,000, and the net result was DKK 9,597,000.
As of June 15, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GLAXOSMITHKLINE PHARMA A/S.
As of June 15, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of GLAXOSMITHKLINE PHARMA A/S.
As of June 15, 2018, Neale Andrew Belson has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of June 15, 2018, Josephine Yang Comiskey has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2016. Revenue came to DKK 366,477,000, and the net result was DKK 1,872,000.
As of April 3, 2017, Josephine Yang Comiskey has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Saskia Fontein has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Daniël Gijbels has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Saskia Fontein is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of April 3, 2017, Josephine Yang Comiskey has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of April 2, 2017, Josephine Yang Comiskey has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2015. Revenue came to DKK 338,938,000, and the net result was DKK 3,665,000.
As of December 2, 2015, Josephine Yang Comiskey has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of December 2, 2015, Judith Lynne Stewart has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of December 2, 2015, Josephine Yang Comiskey is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of December 2, 2015, Judith Lynne Stewart has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2014. Revenue came to DKK 371,489,000, and the net result was DKK 11,764,000.
As of May 26, 2015, Daniël Gijbels has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 26, 2015, Birgit Yvonne Reimann has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of February 20, 2015, is registered as an owner of GLAXOSMITHKLINE PHARMA A/S with an ownership share of 100%.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2013. Revenue came to DKK 364,257,000, and the net result was DKK 14,472,000.
As of October 11, 2013, Judith Lynne Stewart has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of October 11, 2013, Birgit Yvonne Reimann has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of October 11, 2013, Georgios Katzourakis has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of October 11, 2013, Judith Lynne Stewart is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of October 11, 2013, Birgit Yvonne Reimann has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2012.
As of June 6, 2012, Georgios Katzourakis has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of June 6, 2012, Frederik Jan van Snippenberg has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 27, 2012, Michael Francis Connell has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 27, 2012, Birgit Yvonne Reimann is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of April 27, 2012, Michael Francis Connell has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GLAXOSMITHKLINE PHARMA A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of GLAXOSMITHKLINE PHARMA A/S.
As of December 2, 2010, Ole Jensen-Dahm has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of December 2, 2010, Hans Hedegaard has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 19, 2010, Michael Francis Connell has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 19, 2010, Julie Maree Edwards has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 19, 2010, Michael Francis Connell is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of April 19, 2010, Julie Maree Edwards has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of May 6, 2008, Frederik Jan van Snippenberg has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 6, 2008, David Simon Redfern has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2007, Julie Maree Edwards is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2007, Simon Anthony Jose has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of April 13, 2007, Julie Maree Edwards has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 13, 2007, Simon Anthony Jose has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 21, 2006, A/S PSE NR. 4820 has been appointed auditor of GLAXOSMITHKLINE PHARMA A/S.
As of April 21, 2006, Pricewaterhouse Coopers has stepped down as auditor of GLAXOSMITHKLINE PHARMA A/S.
As of September 12, 2005, David Simon Redfern has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of September 12, 2005, Geradus Wilhelmus Maria van Odijk has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 15, 2004, Simon Anthony Jose has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 15, 2004, Michael John Crow has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 15, 2004, Simon Anthony Jose is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of January 15, 2004, Michael John Crow has stepped down as director of GLAXOSMITHKLINE PHARMA A/S.
As of August 1, 2003, Geradus Wilhelmus Maria van Odijk has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of August 1, 2003, Douglas Malcolm Hurt has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2001, Hans Hedegaard has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 1, 2001, Helge Hassel has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 18, 2001, Michael John Crow has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 18, 2001, Douglas Malcolm Hurt has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 18, 2001, Frederik Jan van Snippenberg has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 18, 2001, Siero Keimpe Roosjen has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of January 18, 2001, Michael John Crow is registered as director of GLAXOSMITHKLINE PHARMA A/S.
As of January 18, 2001, Frederik Jan van Snippenberg has stepped down as director of GLAXOSMITHKLINE PHARMA A/S.
As of July 13, 2000, Frederik Jan van Snippenberg has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of July 13, 2000, Frederik Jan van Snippenberg has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of July 13, 2000, Frederik Jan van Snippenberg is registered as director of GLAXOSMITHKLINE PHARMA A/S.
As of July 13, 2000, Frederik Jan van Snippenberg has stepped down as director of GLAXOSMITHKLINE PHARMA A/S.
As of May 11, 2000, Frederik Jan van Snippenberg has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 11, 2000, Carl Christian Juhlsgaard Jepsen has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of May 11, 2000, Frederik Jan van Snippenberg is registered as director of GLAXOSMITHKLINE PHARMA A/S.
As of May 11, 2000, Carl Christian Juhlsgaard Jepsen has stepped down as director of GLAXOSMITHKLINE PHARMA A/S.
As of March 18, 1998, Siero Keimpe Roosjen has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of March 18, 1998, Simon Cresey Davidson has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of April 29, 1996, Angus Robertson has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
On November 10, 1995, the company changed its name from GLAXO DANMARK A/S to GLAXOSMITHKLINE PHARMA A/S.
On November 8, 1995, the company changed its name from GLAXO WELLCOME A/S to GLAXO DANMARK A/S.
On June 13, 1989, the company changed its name from GLAXO LÆGEMIDLER A/S to GLAXO WELLCOME A/S.
As of December 11, 1968, Pricewaterhouse Coopers has been appointed auditor of GLAXOSMITHKLINE PHARMA A/S.
As of December 11, 1968, Helge Hassel has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of December 11, 1968, Carl Christian Juhlsgaard Jepsen has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of December 11, 1968, Angus Robertson has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of December 11, 1968, Simon Cresey Davidson has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of December 11, 1968, Carl Christian Juhlsgaard Jepsen is registered as director of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S was founded on December 11, 1968.
Companies in the same industry and area
CVR 55541817
CVR 16406899
CVR 42541877
CVR 45267024
CVR 43401548
companydata.dk